跳至主要内容
临床试验/JPRN-UMIN000021160
JPRN-UMIN000021160已完成未知

A pharmacokinetics study of edoxaban in non-small cell lung cancer patients harboring EGFR mutation combined with venous thromboembolism - A pharmacokinetics study of edoxaban in non-small cell lung cancer patients harboring EGFR mutation

Shimane University Faculty of Medicine0 个研究点目标入组 20 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • History of allergic reaction for edoxavan Severe renal dysfunction (Ccr under 30 mL/min) Severe liver disease Interstitial pneumonia Plannning for concurrent chemoradiotherapy Started medication or treatment for VTE Active bleeding Severe hypertention A pregnant woman, a woman in breast-feeding Taking aspirin or two kind os antiplatelet drug Acute infectious endocarditis An inappropriate case judged by doctor in charge

研究者

发起方
Shimane University Faculty of Medicine

相似试验

A pharmacokinetics study of edoxaban in non-small... | 临床试验